Hemab Therapeutics
DenmarkEntry
2021
Hold
5yr
Status
Active
Who owns Hemab Therapeutics?
Hemab Therapeutics is currently owned by HealthCap through HealthCap VIII (2021 vintage), since 2021. Across its history, Hemab Therapeutics has been through 3 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-04-21
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2020 · present
Sofinnova PartnersActive
2020 · present(6yr) · Sofinnova Crossover Fund I · 2018 · VC
HealthCapActive
2021 · present(5yr) · HealthCap VIII · 2021 · VC
Novo HoldingsActive
2021 · present(5yr) · Novo Holdings Seed Investments · 1999 · VC
More from HealthCap VIII
Other portfolio companies in the same fund.
Finland
Sweden
US
SwitzerlandMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Track Hemab Therapeutics
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Hemab Therapeutics?
1 strategic and 119financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Hemab Therapeutics.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue